Contextual Genomics

Contextual Genomics, founded and led by international leaders in the field of cancer genomics and bioinformatics, provides end-to-end solutions for clinical laboratories, leveraging genomic data from cancer patients to improve patient diagnosis and offer expanded treatment options for oncologists and patients.Contextual Genomics' end-to-end solution is an NGS liquid and tissue biopsy approach that detects mutations in cancer and is designed to be clinically actionable, clinical-grade (CAP, CLIA validated), and cost-effective. The proprietary cloud-based bioinformatics platform eliminates the need for Contextual Genomics' partner laboratories to invest in any additional R&D and software development, which is an integral part of its product. All solutions from Contextual Genomics are embedded with leading proprietary molecular quality assurance tools, enabling laboratory partners to effectively support oncologists and cancer patients.